Skip to main content
    B

    Biomx Inc (PHGE)

    Official site

    INDUSTRIALS • BIOTECHNOLOGY • AMEX

    $1.85
    +0.23 (+14.20%)

    Market Cap: $5.00M

    Last updated: Sep 10, 2026 at 8:00 PM ET

    Biomx Inc (PHGE) Financials: Revenue, Profit and Cash Flow

    Updated Aug 19, 2026. Financial statements from company filings, amounts in US dollars.

    Biomx reported revenue of -$2.88M for the fiscal year ended Dec 31, 2025, down 111.3% from the year before. That year, net income was -$36.20M, operating cash flow was -$26.39M and free cash flow was -$26.39M. The quarter ended Jun 30, 2026 had revenue of $322.00K and net income of -$3.85M.

    Revenue and Margins

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025-$2.88M-111.3%N/AN/AN/A
    Dec 2024$25.36M+7004.8%-7.1%-153.9%-69.9%
    Dec 2023$357.00KN/A-244.0%-7754.9%-7330.3%
    Dec 2022-$1.94MN/AN/AN/AN/A
    Dec 2021-$699.00KN/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018$0N/AN/AN/AN/A
    Jun 2018N/AN/AN/AN/AN/A
    Dec 2017N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2017 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Jun 2018Dec 2017
    Revenue-$2.88M$25.36M$357.00K-$1.94M-$699.00K$0$0$0N/AN/A
    Cost of revenue$2.92M$1.80M$871.00K$2.52M$2.56M$2.18M$318.00K$210.00KN/A$95.00K
    Gross profit-$2.92M-$1.80M-$871.00K-$2.65M-$2.56M-$2.18M-$405.00K-$210.00KN/A-$95.00K
    Research and development$0$0$0$0$0$0$0$0$0$4.74M
    Operating income-$32.91M-$39.03M-$27.68M-$27.22M-$35.46M-$30.26M-$22.21M-$13.14M-$1.03K-$7.37M
    Net income-$36.20M-$17.73M-$26.17M-$28.32M-$36.23M-$30.09M-$20.56M-$12.72M-$1.03K-$6.43M
    EBITDA-$32.55M-$14.99M-$25.96M-$26.17M-$33.41M-$28.08M-$20.25M-$12.51MN/A-$6.34M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$322.00K-$12.05M-$4.50M-$706.00K-$70.00K$908.00K-$1.24M$20.64M$13.88M-$7.92M$87.00K$89.00K
    Gross profitN/AN/A-$1.15M-$1.24M-$292.00K-$236.00K$2.75M-$322.00K-$331.00K-$229.00KN/A-$219.00K
    Operating incomeN/A-$1.30M-$7.20M-$8.54M-$7.43M-$7.76M$16.68M-$10.53M-$9.72M-$6.79M-$5.27M-$7.79M
    Net income-$3.85M-$19.14M-$13.34M-$9.17M-$6.04M-$7.66M-$14.51M$9.64M$4.47M-$17.33M-$5.49M-$7.91M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $4.94M exceeded cash and equivalents by $583.00K. Shareholder equity was negative, at -$1.30M, as total liabilities of $7.08M exceeded total assets of $5.78M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
    Total assets$5.78M$43.23M$25.03M$45.53M$77.99M$70.36M$92.12M$45.33M$13.99M
    Current assets$5.58M$20.52M$17.63M$36.88M$66.64M$60.67M$84.53M$39.89M$8.47M
    Cash and equivalents$4.36M$16.86M$14.91M$31.33M$62.10M$36.48M$72.26M$8.60M$6.99M
    Total liabilities$7.08M$19.09M$21.95M$24.49M$30.45M$12.89M$7.67M$2.53M$2.46M
    Short-term debt$4.94M$1.88M$5.79M$5.10M$8.25M$3.18M$3.63M$193.00K$40.00K
    Long-term debt$0N/A$5.40M$10.59M$14.41M$0N/A$500.00KN/A
    Shareholder equity-$1.30M$24.15M$3.08M$21.04M$47.53M$57.47M$84.46M$42.80M$11.53M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$28.19M$3.25M$70.24M$26.17M$38.05M$45.65M$43.23M$59.98M$68.62M$81.61M$25.03M$33.06M
    Total liabilities$10.56M$4.13M$71.54M$15.68M$18.89M$21.16M$19.09M$22.08M$48.73M$58.73M$21.95M$24.90M
    Cash and equivalents$347.00K$1.17M$4.96M$6.92M$14.05M$20.12M$17.81M$23.54M$31.61M$43.01M$14.91M$22.45M
    Shareholder equity$10.87M-$881.00K-$1.30M$10.49M$19.16M$24.50M$24.15M$37.90M$27.43M-$9.54M$3.08M$8.15M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Jun 2018Dec 2017
    Operating cash flow-$26.39M-$36.98M-$21.29M-$29.09M-$27.57M-$24.45M-$17.58M-$11.30M-$30-$4.10M
    Capital expenditures$2.00K$30.00K$50.00K$112.00K$3.68M$1.01M$1.31M$137.00K$0$850.00K
    Free cash flow-$26.39M-$37.01M-$21.34M-$29.20M-$31.25M-$25.46M-$18.89M-$11.44M-$30-$4.95M
    Investing cash flow$108.00K$715.00K$1.95M-$2.11M$16.17M-$10.86M$19.74M-$30.04MN/A-$2.12M
    Financing cash flow$13.19M$38.37M$2.90M$292.00K$37.28M$134.00K$61.55M$43.04M$460$12.95M
    Fiscal years ended Dec 2017 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$1.17M-$5.41M-$4.39M-$7.18M-$6.11M-$8.71M-$6.29M-$8.10M-$11.24M-$11.36M-$6.24M-$5.92M
    Capital expendituresN/A$0$0$2.00K$0$0$11.00K$10.00K$9.00K$7.00K$7.00K$32.00K
    Free cash flowN/A-$5.41M-$4.39M-$7.18M-$6.11M-$8.71M-$6.30M-$8.11M-$11.25M-$11.36M-$6.25M-$5.95M
    Last 12 quarters

    Frequently Asked Questions About PHGE

    What is Biomx's annual revenue?

    Biomx reported revenue of -$2.88M for the fiscal year ended Dec 31, 2025.

    How fast is Biomx's revenue growing?

    Revenue was down 111.3% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Biomx profitable?

    No. Biomx reported net income of -$36.20M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does PHGE generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$26.39M minus capital expenditures of $2.00K produced free cash flow of -$26.39M.

    How much debt does Biomx have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $0, short-term debt of $4.94M and cash and equivalents of $4.36M.